Analysts have been eager to weigh in on the Healthcare sector with new ratings on Applied Therapeutics (APLT – Research Report), Carisma Therapeutics (CARM – Research Report) and Recursion Pharmaceuticals (RXRX – Research Report).
Applied Therapeutics (APLT)
Robert W. Baird analyst Brian Skorney maintained a Buy rating on Applied Therapeutics on May 9 and set a price target of $14.00. The company’s shares closed last Monday at $4.43.
According to TipRanks.com, Skorney is a 2-star analyst with an average return of
Currently, the analyst consensus on Applied Therapeutics is a Strong Buy with an average price target of $11.40, which is a 155.6% upside from current levels. In a report issued on May 9, RBC Capital also maintained a Buy rating on the stock with a $12.00 price target.
See today’s best-performing stocks on TipRanks >>
Carisma Therapeutics (CARM)
In a report issued on May 9, Jack Allen from Robert W. Baird maintained a Buy rating on Carisma Therapeutics, with a price target of $10.00. The company’s shares closed last Monday at $1.48, close to its 52-week low of $1.43.
According to TipRanks.com, Allen has 0 stars on 0-5 stars ranking scale with an average return of
Currently, the analyst consensus on Carisma Therapeutics is a Strong Buy with an average price target of $8.50, a 470.5% upside from current levels. In a report issued on May 9, Capital One Financial also reiterated a Buy rating on the stock with a $10.00 price target.
Recursion Pharmaceuticals (RXRX)
In a report issued on May 9, Mani Foroohar from Leerink Partners maintained a Hold rating on Recursion Pharmaceuticals, with a price target of $10.00. The company’s shares closed last Monday at $9.48.
According to TipRanks.com, Foroohar ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Recursion Pharmaceuticals has an analyst consensus of Moderate Buy, with a price target consensus of $13.50.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on APLT:
